RxDoctor Payments Data

Vikas Patel, MD

Adult Reconstructive Orthopaedic Surgery · Frisco, TXNPI 1679983712

Payments from drug & device makers

What this record shows

This record is dominated by education: $10,961 of the $15,737 with a category attached, or 69.7%. 22 manufacturers reported payments, led by Arthrex at 37.3% of the total. Reporting peaked in 2019 at $9,234 and has fallen 93.8% since, to $575 in 2025.

$15,737in general payments, 2019–2025

Across 113 payments — averaging $139.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$6K
  • Micromed Inc$4K
  • Stryker$2K
  • ALON Medical Technology$2K
  • Acumed LLC$1K
  • Alphatec Spine, Inc$356
  • plus $1K from 16 others
$134,625in research payments, 2019–2025

Across 1 payment — averaging $134,625 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Orthofix Medical, Inc.$135K

What the payments were for

  • Travel & lodging$1,2828%
  • Food & beverage$3,49422%
  • Education$10,96170%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,737 in reported general payments places this provider in the 55th percentile of 86 adult reconstructive orthopaedic surgery providers in Texas.

See all adult reconstructive orthopaedic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$116,041
Medicare patients
200
Services billed
1,124

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen100$1,223
Ondansetron OdtOndansetron66$1,100
Pregabalin35$325
Oxycodone Hcl27$175
Methylprednisolone27$166
Tramadol Hcl34$142
Meloxicam23$45

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Frisco

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →